- Report
- March 2024
- 192 Pages
Global
From €3251EUR$3,374USD£2,797GBP
€3612EUR$3,749USD£3,107GBP
- Report
- March 2024
- 247 Pages
Global
From €4023EUR$4,175USD£3,461GBP
- Report
- November 2023
- 143 Pages
Global
From €2408EUR$2,499USD£2,071GBP
- Report
- October 2023
- 110 Pages
Global
From €5733EUR$5,950USD£4,932GBP
- Report
- May 2024
- 196 Pages
Global
From €4770EUR$4,950USD£4,103GBP
- Report
- March 2024
- 175 Pages
Global
From €4818EUR$5,000USD£4,144GBP
- Report
- February 2024
- 175 Pages
Global
From €4818EUR$5,000USD£4,144GBP
- Report
- November 2023
- 142 Pages
Global
From €2408EUR$2,499USD£2,071GBP
- Report
- November 2023
- 146 Pages
Global
From €2408EUR$2,499USD£2,071GBP
- Report
- November 2023
- 148 Pages
Global
From €2408EUR$2,499USD£2,071GBP
- Report
- February 2024
- 178 Pages
Global
From €4722EUR$4,900USD£4,061GBP
- Report
- November 2023
- 179 Pages
Global
From €4722EUR$4,900USD£4,061GBP
- Report
- October 2023
- 170 Pages
Global
From €4722EUR$4,900USD£4,061GBP
- Report
- November 2023
- 178 Pages
Global
From €4722EUR$4,900USD£4,061GBP
- Report
- October 2023
- 181 Pages
Global
From €4722EUR$4,900USD£4,061GBP
- Report
- February 2024
- 120 Pages
Global
From €4577EUR$4,750USD£3,937GBP
- Report
- February 2024
- 115 Pages
Global
From €4577EUR$4,750USD£3,937GBP
- Report
- February 2024
- 110 Pages
Global
From €4577EUR$4,750USD£3,937GBP
- Report
- December 2023
- 140 Pages
Global
From €4288EUR$4,450USD£3,688GBP
- Report
- January 2024
- 200 Pages
Global
From €3999EUR$4,150USD£3,440GBP
Parkinson's Disease (PD) is a progressive neurological disorder that affects movement, muscle control, and balance. It is caused by the death of dopamine-producing neurons in the brain, leading to a decrease in dopamine levels. Symptoms of PD include tremors, stiffness, slowness of movement, and impaired balance. Treatment for PD includes medications, physical therapy, and surgery.
The PD market within the context of Neurology is a rapidly growing field, with a focus on developing treatments that can improve the quality of life for those living with the disease. Companies in this market are researching and developing new therapies, such as gene therapy, stem cell therapy, and deep brain stimulation, as well as developing new drugs to treat the symptoms of PD.
Some companies in the PD market include AbbVie, Acorda Therapeutics, Allergan, Biogen, and Teva Pharmaceuticals. Show Less Read more